These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3516579)

  • 1. The safety of bromocriptine in long-term use: a review of the literature.
    Weil C
    Curr Med Res Opin; 1986; 10(1):25-51. PubMed ID: 3516579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs five years later. Bromocriptine.
    Vance ML; Evans WS; Thorner MO
    Ann Intern Med; 1984 Jan; 100(1):78-91. PubMed ID: 6229205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug therapy: Bromocriptine.
    Parkes D
    N Engl J Med; 1979 Oct; 301(16):873-8. PubMed ID: 384250
    [No Abstract]   [Full Text] [Related]  

  • 4. Pregnancy in an acromegalic after bromocriptine therapy.
    O'Herlihy C
    Ir J Med Sci; 1980 Jul; 149(7):281-2. PubMed ID: 7410043
    [No Abstract]   [Full Text] [Related]  

  • 5. Pregnancy after bromocriptine-induced reduction of an extrasellar prolactin-secreting pituitary macroadenoma.
    Goodman LA; Chang RJ
    Obstet Gynecol; 1984 Sep; 64(3 Suppl):2S-7S. PubMed ID: 6433250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depot-bromocriptine treatment for prolactinomas and acromegaly.
    Grossman A; Ross R; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):231-8. PubMed ID: 3708874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bromocriptine as prophylactic therapy in prolactinoma during pregnancy.
    Canales ES; García IC; Ruíz JE; Zárate A
    Fertil Steril; 1981 Oct; 36(4):524-6. PubMed ID: 7286276
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduction of pituitary-tumour size in patients with prolactinomas and acromegaly treated with bromocriptine with or without radiotherapy.
    Wass JA; Moult PJ; Thorner MO; Dacie JE; Charlesworth M; Jones AE; Besser GM
    Lancet; 1979 Jul; 2(8133):66-9. PubMed ID: 87966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
    Eversmann T; Fahlbusch R; Rjosk HK; von Werder K
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):413-27. PubMed ID: 574700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotic reactions during treatment of pituitary tumours with dopamine agonists.
    Turner TH; Cookson JC; Wass JA; Drury PL; Price PA; Besser GM
    Br Med J (Clin Res Ed); 1984 Oct; 289(6452):1101-3. PubMed ID: 6435792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive mixed growth hormone/prolactin secreting pituitary tumour: complete shrinking by octreotide and bromocriptine, and lack of tumour growth relapse 20 months after octreotide withdrawal.
    Sadoul JL; Thyss A; Freychet P
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):179-83. PubMed ID: 1543025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of prolactinomas and growth hormone-producing adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump.
    Schatz H; Stracke H; Hildebrandt G
    Pathol Res Pract; 1988 Sep; 183(5):546-51. PubMed ID: 3237541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
    Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K
    Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine and pituitary disorders.
    Kellett J; Friesen HG
    Ann Intern Med; 1979 Jun; 90(6):980-2. PubMed ID: 443696
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term follow-up of hyperprolactinemic women treated with bromocriptine.
    Corenblum B; Taylor PJ
    Fertil Steril; 1983 Nov; 40(5):596-9. PubMed ID: 6628704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromocriptine update.
    Borowski GD; Rose LI
    Am Fam Physician; 1984 Aug; 30(2):218-20. PubMed ID: 6464960
    [No Abstract]   [Full Text] [Related]  

  • 18. Bromocriptine-induced changes in hormone secretion and cell morphology in growth hormone and prolactin producing pituitary adenomas.
    Anniko M; Werner S; Wersäll J
    Acta Otolaryngol; 1981; 92(3-4):343-55. PubMed ID: 7324902
    [No Abstract]   [Full Text] [Related]  

  • 19. [Medical treatment of functioning pituitary adenomas (author's transl)].
    Yamaji T
    No To Shinkei; 1981 May; 33(5):449-59. PubMed ID: 7259908
    [No Abstract]   [Full Text] [Related]  

  • 20. Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma.
    Holness RO; Shlossberg AH; Heffernan LP
    Neurology; 1984 Jan; 34(1):111-3. PubMed ID: 6537833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.